Global Medical REIT Inc. (NYSE:GMRE) Short Interest Update

Global Medical REIT Inc. (NYSE:GMRE - Get Free Report) was the recipient of a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 1,320,000 shares, an increase of 7.3% from the March 31st total of 1,230,000 shares. Based on an average daily volume of 399,800 shares, the days-to-cover ratio is currently 3.3 days.

Institutional Trading of Global Medical REIT

Several institutional investors and hedge funds have recently added to or reduced their stakes in GMRE. AJOVista LLC purchased a new position in shares of Global Medical REIT during the 4th quarter worth approximately $54,000. Quadrant Capital Group LLC raised its stake in shares of Global Medical REIT by 41.5% during the 4th quarter. Quadrant Capital Group LLC now owns 5,679 shares of the company's stock worth $63,000 after buying an additional 1,666 shares in the last quarter. Creekmur Asset Management LLC purchased a new position in shares of Global Medical REIT during the 4th quarter worth approximately $92,000. New York Life Investment Management LLC purchased a new position in shares of Global Medical REIT during the 4th quarter worth approximately $115,000. Finally, Versor Investments LP purchased a new position in shares of Global Medical REIT during the 3rd quarter worth approximately $93,000. 57.52% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, StockNews.com cut Global Medical REIT from a "buy" rating to a "hold" rating in a research report on Wednesday, February 28th.


Read Our Latest Report on Global Medical REIT

Global Medical REIT Stock Performance

GMRE traded up $0.01 on Wednesday, hitting $8.12. 765,686 shares of the company traded hands, compared to its average volume of 386,298. The company has a 50 day moving average of $8.60 and a 200-day moving average of $9.51. The company has a quick ratio of 0.17, a current ratio of 0.17 and a debt-to-equity ratio of 1.11. The stock has a market capitalization of $532.43 million, a PE ratio of 35.30 and a beta of 1.12. Global Medical REIT has a 12-month low of $7.98 and a 12-month high of $11.59.

Global Medical REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 9th. Shareholders of record on Friday, March 22nd were paid a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 10.34%. The ex-dividend date of this dividend was Thursday, March 21st. Global Medical REIT's dividend payout ratio is presently 365.22%.

About Global Medical REIT

(Get Free Report)

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ A ‘DeFi Summer’ Projected! (From Crypto 101 Media) (Ad)

Should you invest $1,000 in Global Medical REIT right now?

Before you consider Global Medical REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.

While Global Medical REIT currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Featured Articles and Offers

AMD is Down 35%. Now is the Time to Buy the Dip

AMD is Down 35%. Now is the Time to Buy the Dip

AMD stock is at a critical turning point. The market is down 7% following the release but showing some signs of support at a key level. That level aligns with the prior lows and maybe the bottom for t

Search Headlines: